Genomics

Dataset Information

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer.


ABSTRACT: Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer.

PROVIDER: PRJNA981495 | ENA |

REPOSITORIES: ENA